Latest Stock Market News

Manish Sonthalia of Emkay Investment Managers highlights the impact of macroeconomic changes on India s market, particularly regarding de-dollarisation and fiscal policies. He notes the benefits for discretionary spending and consumption stocks due to income tax savings and potential growth in government salaries. Additionally, he emphasizes valuation concerns in capex stocks despite government initiatives.

Gold April futures experienced profit booking on Monday after reaching a new high of Rs 88,310 per 10 grams last week. Manoj Kumar Jain of Prithvifinmart Commodity Research suggests volatility in bullion prices amid US trade war and FED policy meetings. Silver May futures also remained above Rs 1 lakh per kilogram, despite some profit-taking.

Peter Schiff warned that Bitcoin could face a sharp decline if the Nasdaq enters a bear market. He noted that past crashes saw the index drop up to 80% and predicted that if it falls 40% this time, Bitcoin could plunge to $20,000 or lower. Schiff sees Bitcoin’s correlation with stocks as a major risk.

JM Financial recommends buying PVR INOX with a target price of Rs 1610. Currently, PVR INOX is priced at Rs 925. The company, established in 1995, operates in the Media & Entertainment sector, reporting a quarterly income of Rs 1759.10 crore. Strong box office collections and a good movie pipeline may support its growth. Valuation appears reasonable.

If you look at the biggest gainer, the crude prices which has cooled off and inflation below sub-4, RBI s interventions what we have seen, so all these things are just getting a base for our markets to move up and as I said, it will be a stock pickers and the stock specific rather than the entire market selling into it.

The Nifty Auto index was trading 0.66 per cent up at 20690.7.

MobiKwik shares: The stock has seen a sharp decline, falling 61% from its post-listing high of nearly Rs 700. It has also dropped below its IPO price of Rs 269, increasing investor concerns. Over the past week, shares have fallen by 13%, and in the last month, the decline has deepened to 24%.

Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) for IBS-D treatment. The company secured 180 days of shared generic drug exclusivity. Analysts set an average target price of Rs 1,066, indicating a 21% upside, though technical indicators suggest a bearish trend.

IRFC dividend date 2025: IRFC’s board is set to meet today, March 17, to approve its second interim dividend for FY 2024-25. Over the past 12 months, the company has declared Rs 1.50 per share in dividends, with a 1.27% yield. Meanwhile, IRFC shares have declined 13.78% YoY, with a 21.52% YTD drop, reflecting a persistent downtrend.